Lilly’s weight loss drug reduces diabetes risk in overweight patients
Eli Lilly’s weight-loss drug Zepbound dramatically reduces the risk of developing type 2 diabetes in overweight or obese pre-diabetic adults after three years of weekly injections, the drug’s maker said Tuesday.
ENTRADAS POPULARES
Portugal declares risk as wildfires hit the north of the country
septiembre 17, 2024
UK to appoint nature envoy
septiembre 17, 2024
Death tolls rises as Central Europe floods
septiembre 17, 2024
‘The Twelve’, a drama starring Sam Neill, has been renewed for a third season
septiembre 17, 2024
TRANSMISIÓN EN VIVO